Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host disease

Cellular and Molecular Immunology

Volumn 7, Issue 2, 2010, Pages 133-142

  Li, Na ^a   Zhu, Faliang ^a   Gao, Fei ^a   Wang, Qun ^a   Wang, Xiaoyan ^a   Li, Haiyan ^a   Ma, Chunhong ^a   Sun, Wensheng ^a   Xu, Wenfang ^a   Wang, Chaodong ^b   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

CD28; Peptoid; Phage display

Indexed keywords

ALLOANTIGEN; AMINO ACID; CD28 ANTIGEN; FC RECEPTOR; GLYCINE DERIVATIVE; HOMODIMER; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PEPTOID; PROTEINASE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR DOCKING; MOLECULAR MODEL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERMEABILITY; PHAGE DISPLAY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; CELL PROLIFERATION; CELLS, CULTURED; GRAFT VS HOST DISEASE; HUMANS; MICE; MODELS, MOLECULAR; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; T-LYMPHOCYTES;

EID: 77749283634     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.120     Document Type: Article

References (31)

1. Schwartz RH. A cell culture moDel for T lymphocyte clonal anergy. Science 1990; 258: 1349.
2. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990;11: 211.
3. Shahinian A, Pfeffer K, Lee KP, Kü ndig TM, Kishihara K, Wakeham A et al. Differential T cell costimulatory requirements in CD28-Deficient mice. Science 1993; 261: 609.
4. Thompson CB, Lindsten T, Ledbetter JA, Kunkel SL, Young HA, Emerson SG et al. CD28 activation pathway regulates the production of multiple T-cell-Derived lymphokines/cytokines. Proc Natl Acad Sci USA 1989; 86: 1333.
5. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321.
6. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
7. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607.
8. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586.
9. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561-569.
10. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116-126.
11. Miller SD, VanDerlugt CL, Lenschow DJ. BlockaDe of CD28/B7-1 interaction prevents epitope spreading and clinical relapse of murine EAE. Immunity 1995; 3: 739-745.
12. Newell KA, He G, Guo Z, Kim O, Szot GL, Rulifson I et al. Cutting edge: blockaDe of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD41 but not CD81 T cells. J Immunol 1999; 163: 2358-2362.
13. Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 1995; 96: 2195.
14. Perrin PJ, Scott D, Davis TA, Gray GS, Doggett MJ, Abe R et al. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephal-omyelitis. J Neuroimmunol 1996; 65: 31.
15. Perrin PJ, June CH, Maldonado JH, Ratts RB, Racke MK. BlockaDe of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 1999; 163: 1704-1710.
16. Marx V. Watching peptiDe drugs grow up. Chem Eng News 2005; 83: 17-24.
17. Caudic P, Stawikowski M. Peptidomimetics: Fmoc solid-phase pseudopeptiDe synthesis. Methods Mol Biol 2008; 494: 223-246.
18. Kirshenbaum K, Zuckermann RN, Dill KA. Designing polymers that mimic biomolecules. Curr Opin Struct Biol 1999; 9: 530-535.
19. Gellman SH. Foldamers: a manifesto. Acc Chem Res 1998; 31: 173-180.
20. Barron AE, Zuckermann RN. Bioinspired polymeric materials: in-between plastics and proteins. Curr Opin Chem Biol 1999; 3: 681-687.
21. Figliozzi GM, Goldsmith R, Ng SC, Banville SC, Zuckermann RN. Synthesis of Nsubstituted glycine peptoid libraries. Methods Enzymol 1996; 267: 437-447. (Pubitemid 26159237)
22. Kirshenbaum K, Barron AE, Goldsmith RA, Armand P, Bradley EK, Truong KT et al. Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc Natl Acad Sci USA 1998; 95: 4303-4308.
23. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821
24. Larsen CP, Elwood ET, AlexanDer DZ, Ritchie SC, Hendrix R, Tucker-BurDen C et al. Long term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
25. Lechler R, Sykes M, Thomson AW, Turka LA. Organ transplantation-how much of the promise has been realized. Nat Med 2005; 11: 605-613.
26. Khoury SJ, Sayegh MH. The roles of the new negative T-cell costimulatory pathways in regulating autoimmunity. Immunity 2004; 20: 529-538.
27. Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: challenges and new Developments. Immunol Rev 2009; 229: 271-293.
28. BarbasIIICF, Wagner J. Synthetic human antibodies: selecting and evolving functional proteins. Methods 1995; 8: 94-103.
29. Tayapiwatana C, Kasinrerk W. Construction and characterization of phage-displayed leukocyte surface molecule CD99. Appl Microbiol Biotechnol 2002; 60: 336-341.
30. Tayapiwatana C, Arooncharus P, Kasinrerk W. Displaying and epitope mapping of CD147 on VCSM13 phages: influence of Escherichia coli strains. J Immunol Methods 2003; 281: 177-185.
31. Manosroi J, Tayapiwatana C, Gotz F, Werner RG, Manosroi A. Secretion of active recombinant human tissue plasminogen activator Derivatives in Escherichia coli. Appl Environ Microbiol 2001; 67: 2657-2664.